Displaying all 6 publications

Abstract:
Sort:
  1. Wan Nor Aida, W.M.S., Aaina Iryani, M., Ahmad Khaldun, I.
    Medicine & Health, 2020;15(1):288-293.
    MyJurnal
    Fraktur avulsi tulang belakang iliac anterior (ASIS) jarang terjadi, dan lebih lumrah berlaku di kalangan remaja muda semasa bersukan. Ini disebabkan oleh rawan apophyseal yang lemah semasa remaja, apabila kontraksi otot yang kuat mengatasi ASIS semasa aktiviti olahraga. Seorang lelaki berusia 15 tahun dibawa ke Jabatan Kecemasan (ED) mengadu sakit pinggul kanan selepas perlumbaan semasa Hari Sukan sekolahnya. Ketika dia melintasi garisan penamat dan menang, dia tiba-tiba rasa sensasi “pop” di pinggul kanannya dan jatuh ke tanah dengan kesakitan. Di ED, dia baring meniarap dengan skor sakit 6/10. Intravena Ketorolac diberikan untuk melegakan kesakitannya. Pemeriksaan fizikal menunjukkan kesakitan setempat di kawasan hadapan pelvis kanan, tanpa bengkak atau kecacatan pada sendi pinggul kanan. Tiada perbezaan antara kepanjangan kaki kanan berbanding kaki kiri. Pergerakan pinggul kanan terhad akibat kesakitan. Pemeriksaan neurovaskular adalah normal. Radiografi pelvis menunjukkan fraktur avulsi ASIS kanan. Beliau telah dirujuk kepada pasukan Ortopedik dan telah dirancang untuk rawatan konservatif rehat di katil, analgesik, dan ambulansi tanpa berat. Dia dibenarkan pulang dan dirancang untuk temujanji di Klinik Ortopedik. Pemeriksaan semula selepas 2 bulan kecederaan menunjukkan pesakit sihat dan bebas kesakitan. ASIS mudah terdedah kepada kecederaan avulsi semasa menjalankan aktiviti sukan kerana otot sartorius menarik anteroinferior ASIS semasa lekukan maksimum pinggul dan lanjutan lutut. Walaupun fraktur avulsi apophyses pelvis jarang berlaku, ia harus dipertimbangkan di kalangan atlet remaja jika mekanisma kecederaan adalah sangat sugestif.

    Matched MeSH terms: Ketorolac
  2. Muralidharan S, Jayaraja Kumar K, Parasuraman S
    J Young Pharm, 2013 Sep;5(3):98-101.
    PMID: 24396250 DOI: 10.1016/j.jyp.2013.06.007
    To develop a simple and sensitive method of ketorolac in drug free human plasma using high-performance liquid chromatographic (HPLC).
    Matched MeSH terms: Ketorolac
  3. Chewa Raja JS, Singh S, Ismail F
    J Ocul Pharmacol Ther, 2021 Jun;37(5):313-317.
    PMID: 33794664 DOI: 10.1089/jop.2020.0089
    Purpose: To evaluate the efficacy of topical ketorolac tromethamine 0.5% given pre-emptively a day before, for alleviating pain in patients undergoing panretinal photocoagulation (PRP) treatment. Methods: A controlled single-blinded study was conducted on 33 patients with diabetic retinopathy (DR; severe nonproliferative DR, proliferative DR, or advanced diabetic eye disease) who required PRP treatment in both eyes simultaneously. Each eye of the patients was randomly assigned for ketorolac tromethamine 0.5% eyedrop or placebo. Both eyedrop bottles were randomly labeled. Eyedrops were self-administered by the patients, 4 times a day before the procedure (at 6 am, 12 noon, 6 pm, and 12 midnight) and every 15 min for 1 h (4 times) before the laser. Each patient was subjected to PRP using a Visulas 532s Zeiss device set to spot size 200 μm, time 0.10 s, and ∼600 burns in each eye. The pain score was evaluated immediately after treatment in each eye independently with Scott's visual analog scale (VAS) and the McGill Pain Questionnaire (MPQ). Results: VAS pain score in ketorolac-treated eyes (median 3.0, interquatile range [IQR] ±2.5) was lower than in placebo-treated eyes (median 5.0, IQR ±3.0). Total Pain Rate Index score from MPQ was lower in ketorolac-treated eyes (median 3.0, IQR ±3.0) than in placebo-treated eyes (median 3.0, IQR ±2.5). Both pain score differences are statistically significant with P ˂ 0.05. Conclusion: Topical ketorolac tromethamine 0.5% given pre-emptively a day before is effective in alleviating pain in patients undergoing PRP treatment.
    Matched MeSH terms: Ketorolac Tromethamine/administration & dosage; Ketorolac Tromethamine/adverse effects; Ketorolac Tromethamine/pharmacology*; Ketorolac Tromethamine/therapeutic use
  4. Sabran, M.N., Talha, A.J.M., Omar, M., Ibrahim, M.Y., Shahril, Y.
    Malays Orthop J, 2008;2(2):21-26.
    MyJurnal
    This is a prospective randomized clinical trial to compare use of a combination of periarticular drug injection with patientcontrolled analgesia (PCA) to PCA alone in post-total knee arthroplasty (TKA). Thirty patients who were admitted for unilateral total knee arthroplasty were selected randomly into an Injection group or a Standard group. The periarticular injection contained Ropivacaine, Ketorolac and Adrenaline, given intra-operatively. The mean amount of opioid used was 22.87 mmol/L in the Injection group as compared to 39.78 mmol/L in the Standard group (p = 0.026). The Injection group had lower pain score at rest and during exercise (p=0.021, p=0.041, respectively), as well as better return to function (p=0.026) and shorter hospital stay (6.1 days, Injection; 7.5 days, Standard, p=0.027). Overall, the group receiving periarticular drugs injection had less pain, less narcotic usage, earlier return to function, similar experience of adverse effects and shorter hospital stays.
    Matched MeSH terms: Ketorolac
  5. Rao SK, Rao PS
    Med J Malaysia, 2005 Dec;60(5):560-2.
    PMID: 16515105
    Post Arthroscopic intra-articular analgesia is a better method to avoid post-operative pain after arthroscopic surgery, thus avoiding the adverse effects of systemic analgesics. In this prospective randomized double blind study conducted on 90 patients, 30 patients in group A received 20 ml of intra-articular saline, 30 patients in Group B received 10 ml of intra-articular saline and 10 ml of 0.25% bupivacaine and 30 patients in Group C received 10 ml of 0.25% bupivacaine, 1 ml (30 mg) of ketorolac and 9 ml of saline intra-articularly. Ambulatory status, duration of analgesia and requirement for supplemented analgesia were compared in these three groups. Patients receiving this intra-articular analgesic combination of bupivacaine and ketorolac required significantly less supplemental postoperative analgesics. This combination significantly prolonged the duration of analgesia. Patients receiving this combination of drugs for intra-articular analgesia ambulated earlier.
    Matched MeSH terms: Ketorolac/administration & dosage*
  6. Nagendrababu V, Pulikkotil SJ, Jinatongthai P, Veettil SK, Teerawattanapong N, Gutmann JL
    J Endod, 2019 Apr;45(4):364-371.
    PMID: 30737050 DOI: 10.1016/j.joen.2018.10.016
    INTRODUCTION: This review aimed to find the most effective oral premedication in reducing pain in adults after nonsurgical root canal therapy (NSRCT) using network meta-analysis.

    METHODS: The review protocol was registered in the PROSPERO database (CRD42017071899). A literature search was performed in the MEDLINE and EBSCOhost databases until June 2017 with no language restriction. Randomized controlled trials evaluating the efficacy of oral premedications, whether given alone or in combination, compared with other agents, placebo, or no treatment in adult patients before NSRCT for postoperative pain were included. Nonintervention studies, nonendodontic studies, animal studies, and reviews were excluded. The quality of the studies was assessed using the revised Cochrane risk of bias tool. Pair-wise meta-analysis, network meta-analysis, and quality of evidence assessment using the Grading of Recommendations Assessment, Development and Evaluation criteria was performed.

    RESULTS: Eleven studies comparing pharmacologic groups of medications were included in the primary analysis. Compared with placebo, corticosteroids (prednisolone 30-40 mg) was ranked best for reducing postoperative pain (median difference [MD] = -18.14 [95% confidence interval (CI), -32.90 to -3.37] for the pain score at 6 hours; MD = -22.17 [95% CI, -36.03 to -8.32] for the pain score at 12 hours; and MD = -21.50 [95% CI, -37.95 to -5.06] for the pain score at 24 hours). However, the evidence was very low (6 and 24 hours) to moderate quality (12 hours). Nonsteroidal anti-inflammatory drugs were ranked least among the medications, and the quality of this evidence was very low. Additional analysis based on the chemical name showed that sulindac, ketorolac, and ibuprofen significantly reduced pain at 6 hours, whereas piroxicam and prednisolone significantly reduced the pain at 12 and 24 hours. Etodolac was found to be least effective in reducing pain. Overall, the evidence was of moderate to very low quality.

    CONCLUSIONS: Based on the limited and low-quality evidence, oral premedication with piroxicam or prednisolone could be recommended for controlling postoperative pain after NSRCT. However, more trials are warranted to confirm the results with a higher quality of evidence.

    Matched MeSH terms: Ketorolac/administration & dosage
Filters
Contact Us

Please provide feedback to Administrator (afdal@afpm.org.my)

External Links